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Abstract 
Moyamoya disease is a rare entity characterized by progressive narrowing of intracranial blood 
vessels.  In most cases, Moyamoya does not respond well to medical therapy and often leads to 
surgical revascularization.  The physiological benefits of the revascularization surgery for 
Moyamoya patients have been well documented, yet the effects of surgery on cognitive skills 
and abilities are far less studied.  Participants in the current study were 33 patients, 24 to 85 years 
of age, who underwent revascularization surgery at the Mayo Clinic in Jacksonville, Florida.  All 
patients underwent a physical and cognitive preoperative evaluation, where speech, memory, and 
intellectual processes were measured.  After surgery, patients returned for three follow-up 
assessments over a period of six months.  All patients experienced stabilization or improvement 
of physiological symptoms.  Regarding cognitive functions, speech, memory, and intellectual 
processes improved significantly after surgery.  Results showed not only a reduction of 
physiological symptoms, but also a significant cognitive improvement postsurgery.  This study 
adds to the research of this disease and to the benefits of treatment.  More research can only 
strengthen these findings and educate healthcare professionals; helping them reaffirm Moyamoya 
patients have a better quality of life, by reinforcing the benefits of revascularization surgery. 
 
 
 
 
 
 
vi 
Cognitive Improvement After Microsurgical Revascularization for the Treatment of 
Moyamoya Disease. 
Japanese doctors first described Moyamoya as hypoplasia of the bilateral internal carotid 
arteries in 1957 (Scott & Smith, 2009).  Moyamoya is a Japanese word that literally means 
“something hazy, like a puff of cigarette smoke” (Ikezaki & Loftus, 2001, p. 1).   Moyamoya  
disease leads not only to a different degree of stenosis and occlusions of large arteries of the 
anterior part of the Willis circle, but also to the development of the collateral vasculature that 
produces a typical angiographic image, that resemble a ‘puff of cigarette smoke’ (Tarasow, 
Kulakowska, Lukasiewickz, Kapica-Topczewska, Korneluk-Sadzynska, Brzozowska, 
Drozdowski, 2011).  Moyamoya disease has also been termed “bilateral hypoplasia of the 
internal carotid arteries,” “cerebral juxta-basal telangiectasia,” “cerebral arterial rete,” “rete 
mirabile,” “cerebral basal rete mirabile,” and, more commonly, “spontaneous occlusion of the 
circle of Willis” (Burke, Burke, Sherma, Hurley, Batjer & Bendok, 2009).  Patients with bilateral 
pathognomonic arteriographic findings are said to have Moyamoya disease and patients with 
unilateral findings have the Moyamoya syndrome (Scott & Smith, 2009).  The term quasi-
moyamoya disease is typically used to refer to patients who display steno-occlusive lesions and 
associated collaterals in other areas of the brain or who have systemic disorders that account for 
the observed vasculopathy (Zipfel, Fox & Rivet, 2005).   
For a patient to be diagnosed with Moyamoya disease, four criteria need to be met; first, 
stenosis or occlusion of the terminal portion of the internal carotid artery; second, a coexisting 
abnormal vascular network in the base of the brain or basal ganglia; third, bilaterality; and 
fourth, no other identifiable cause (Fukui, 1997).  These criteria indicate that both sides of the 
brain have to demonstrate a narrowing of the arteries, causing an obstruction that leads to a 
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diminishing blood flow in the brain.  The brain will look for new routes to compensate for the 
blockage by creating an abnormal vascular network, and if the blockage is not caused by any 
other source, such as a tumor, it is said that the patient has Moyamoya disease.  
 The minister of Health and Welfare of Japan has subdivided Moyamoya presentation 
into 4 categories: ischemic (63.4%), hemorrhagic (21.6%), epileptic (7.6%), and other (7.5%).  
In the United States the most common mode of presentation is ischemia in both children and 
adults, whereas the hemorrhagic presentation is comparatively rare (Weinberg, Rahme, Aoun, 
Batjer & Bendok, 2011). 
Although the pathophysiology of Moyamoya disease is yet to be fully understood, several 
angiogenic and cellular proliferative proteins have been associated with Moyamoya disease, such 
as Vascular Endothelial Growth Factor (a 45-kD homodimeric), upregulated  expression of 
Vascular Endothelial Growth Factor A (VEGF-A), abnormal elevation in the cerebrospinal fluid 
of Basic Fibroblast Growth Factor (18-kD protein), significant increase in both Hepatocyte 
Growth Factor and its receptor c-Met in the tunica media and intima, upregulation of 
Transforming Growth Factor–b1, and an elevation of Granulocyte Colony-Stimulating Factor 
were all found in patients with Moyamoya disease (Weinberg,  Arnaout, Rahme, Aoun, Batjer & 
Bendok,2011). 
 Moyamoya has been observed throughout the world in people with various ethnic 
backgrounds (Scott & Smith, 2009).  The incidence peaks in two ages: the early peak around five 
years old and a later peak around 36 years old.  The incidence of the disease in Japan is 0.35 per 
100,000 persons, in the United States (US) is significantly lower 0.086 cases per 100,000 persons 
indicating a genetic component (Weinberg, Rahme, Aoun, Batjer, & Bendok, 2011).  For every 
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White Moyamoya patient in the United States, reported incidence-rate ratios are 4.6 for Asian 
Americans, 2.2 for Blacks, and 0.5 for Hispanics (Scott & Smith, 2009).   
There is an ethnic predisposition to Moyamoya disease, the incidence of the disease being 
the highest in the Asian population worldwide, over 10% of Moyamoya patients have affected 
blood relatives; concordance in the affection status has been proven in 80% of identical twins 
(Hashikata, Mineharu, Takenaka, Houkin,Kuroda, Kikuchi,kimura,Taki, Sonobe, Ban, Nogaki, 
Handa, Kikuta, Takagi, Nozaki, Hashimoto, Koizumi, 2008).  The inheritance pattern of 
Moyamoya is autosomal dominant with incomplete penetrance, there is a major gene locus for 
autosomal dominant Moyamoya disease on chromosome 17q25.3 (Mineharu, Liu, Inoue, 
Matsuura, Inoue, Takenaka, Ikeda, Houkin, Takagi,  Kikuta, Nozaki, Hashimoto, Koizumi, 
2008). 
The narrowing of the arteries of the anterior part of the Circle of Willis are produced by 
the thickening and cellular proliferation in the vessel wall, causing a cerebralvascular 
hemodynamic impairment in Moyamoya patients, which means the stenosis are causing a 
irregular blood flow in the brain (Festa, Schwarz, Pliskin, Cullum, Lacritz, Charbel, & Lazar, 
2010).  In the case of Moyamoya patients the narrowing of the arteries cause hypoperfusion, 
reduced blood flow, in the major vessels of the anterior circulation of the brain and can lead to 
various symptoms (Golby, Marks, Thompson, & Steinberg, 1999).  Moyamoya patients’ 
common physiological complaints are stroke, seizures, hemorrhage, headache, and transient 
ischemic attacks (TIAs) also known as mini-strokes causing slurred speech, loss or diminished 
vision and mental confusion, but unlike stroke, TIA symptoms can resolve within few minutes 
(Guzman, Lee, Achrol, Bell-Stephens, Kelly, & Do, 2009).  In addition, it has been observed that 
Moyamoya disease can impair cognition.  
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 Cognitive impairment is a long-term complication for adult with Moyamoya Disease 
(Su, Hai, Zhang, Yu & Wu, 2013).  Although some cognitive decline is expected with aging, 
cognitive impairment is an intermediate stage between the expected cognitive decline of normal 
aging and the more serious decline of dementia (Salthouse, Atkinson, & Berish, 2003).  It can 
involve problems with memory, language, thinking and judgment that are greater than normal 
age-related changes.  Cognitive impairment caused by vascular diseases such as Moyamoya is 
known as Vascular Cognitive Impairment (VCI),  it is a syndrome that takes into account the 
spectrum of cognitive severity, which often includes executive dysfunction and the various types 
of brain vascular disease that could underlie cognitive symptoms, including subclinical vascular 
brain injury, common in Moyamoya patients (Gorelick, Scuteri, Black, DeCarli, Greenberg, 
Iadecola, Launer, Laurent, Lopez, Nyenhuis, Petersen, Schneider, Tzourio, Arnett, Bennett, 
Chui, Higashida, Lindquist, Nilsson, Roman, Sellke, & Seshadric, 2011). When vascular 
damage occurs in the brain, it compromise neural activity and hence causing cognitive 
impairment (Burke,  Hickie, Breakspear, & Götz, 2007).    
Cognitive executive functioning, which includes working memory, reasoning, task 
flexibility, and problem solving, is the most affected in Moyamoya patients, followed by 
memory (short and long term memory) and intellectual impairment to some extent (Karzmark,  
Zeifert, Tan, Dorfman, Bell-Stephens, & Steinberg, 2008). Cognitive executive functioning can 
be described as the control processes responsible for planning, assembling, coordinating, 
sequencing, and monitoring other cognitive operations (Salthouse, Atkinson, & Berish, 2003). 
Analysis of existing literature revealed executive function to be considerably impaired in adult 
Moyamoya patients, due to its in executive function, the frontal lobe, is thought to be directly 
affected in adult Moyamoya patients.  The subcortical and frontal system was also found to be 
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impaired in Moyamoya patients due to chronic hypoperfusion (Weinberg, Rahme, Aoun, Batjer 
& Bendok, 2011).  
On the study “Moyamoya disease: functional and neurocognitive outcomes in the 
pediatric and adult populations”, by Dr. Weinberg et al., indicate the 2 most common tests to 
assess memory in Moyamoya adult patients are the California Verbal Learning Test II (CVRS-
II) and the Wechsler Memory Test – Revised Visual Reproduction System (WMT-RVRS). 31% 
of their patients showed memory dysfunction.  For speech they used the Delis-Kaplan Executive 
Function System (D-KEFS) and they found that 47% of their patients showed fluency 
impairment.  Although they recommend revascularization for treating Moyamoya, and they 
reported that the surgery is beneficial to both physiological and cognitive outcome, their study 
did not focus on post-operative results. (Weinberg, Rahme, Aoun, Batjer & Bendok, 2011).  
The Institute of Moyamoya Disease at Stanford University, conducted a study on the 
“Effect of Moyamoya disease on neuropsychological functioning in adult”, the 
neuropsychological tests chosen by Dr. Steinberg and colleagues, to assess memory impairment 
was CVRS-II and the WMT-RVRS as well, their study showed that 19% of their patients had 
memory impairment.  To assess speech impairment they used the D-KEFS, and 47 % of their 
patients demonstrated fluency impairment, and for intellectual process the test used was the Trail 
Making Test Part A; and 39 % of their patients presented impairment in that area (Karzmark, 
Zeifert, , Tan,  Dorfman, , Bell-Stephens, & Steinberg,2008).  
Although Moyamoya symptoms and signs do not differ much from the manifestation of 
other cerebral vascular diseases, Moyamoya presents a faster clinical and angiographic 
progression, so it should be diagnosed and treated as early as possible to minimize permanent 
neurological deficits (Ikezaki & Loftus, 2001), within several years onset if left Moyamoya 
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disease untreated, the Moyamoya patient can progress to a vegetative state (Burke, Burke, 
Sherma, Hurley, Batjer & Bendok, 2009).  Because of the similarity of symptoms with many 
cerebral-vascular diseases, Moymoya can only be confirmed and diagnosed when the four 
criteria cited earlier are met and can be confirmed by Magnetic Resonance Imaging (MRI) and 
angiograms.  MRI is the investigative tool of choice for neurological disease because it gives a 
better visualization of the brain and is more sensitive than computed tomography.  Furthermore, 
angiograms also allow the doctor to visualize the arterial and venous supply to the brain, making 
it possible to diagnose Moyamoya with precision (Ikezaki & Loftus, 2001, p. 5).  
Moyamoya is a progressive disease and in most cases “does not respond to medical 
therapy with vasodilator or antithrombotic agents” (Steinberg et al., 1999, p. 50).  Various 
medical regimens have been investigated for the treatment of Moyamoya disease, including 
aspirin, steroids, vasodilators, mannitol, low-molecular-weight dextran, and antibiotics, all of 
which have thus far proven ineffective (Zipfel, Fox & Rivet, 2005). If left untreated, the 
morbidity is estimated to be greater than 70% (Guzman & Steinberg, 2011).  Surgical 
intervention has become the standard of treatment of patients with Moyamoya. 
There are three surgical treatments for revascularization surgery: direct, indirect, and a 
combination of direct/indirect revascularization.  There is no optimal surgical treatment for 
Moyamoya, the indirect bypass is considered easier and safer, and leads to fewer periprocedure 
complications (Starke, Komotar, & Connolly, 2009).  The indirect procedure is the 
recommended surgical procedure in the treatment of children with Moyamoya disease, because 
of the fragility of their arteries (Matsushima, Inoue, Ikezaki, Matsukado, Natori, Inamura & 
Fukui, 1998).  However the direct bypass procedure was found to result in the best postoperative 
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collateral vessel formation and clinical improvement (Matsushima, Inoue, Ikezaki, Matsukado, 
Natori, Inamura & Fukui, 1998).   
The encephalo-duro-arterio-synangiosis is a common indirect surgical method used for 
providing more blood flow to the brains of Moyamoya patients.  It uses a branch of the 
superficial temporal artery, which is laid straight on the surface of the brain without doing a 
direct anastomosis.  It takes between six to eight weeks to grow new arteries into the brain and 
therefore provide more blood flow (Ikezaki & Loftus, 2001, p. 44).  All patients in the present 
study underwent the direct revascularization, called extracranial to intracranial bypass or EC-IC 
bypass.  The direct bypass is a straightforward technique of anastomosis (reconnection) of the 
superficial temporal artery and middle cerebral artery (Houkin, Ishikawa, & Yoshimoto, 1997).  
This intervention is often chosen because its effects are immediate after the procedure, it offers a 
good collateral circulation, and it is more reliable than the indirect procedure in reducing 
hemodynamic stress to the Moymoya vessels (Ikezaki & Loftus, 2001).  
Previous research indicates that all three procedures; direct, indirect and the combination 
of indirect/direct revascularization surgery in patients with Moyamoya disease is effective at 
preventing future ischemic event.  Of all patients that presented with TIA, prior to the 
revascularization, 91.8% were free of transient ischemic attacks one year or later (Gudzman et 
al., 2009).  Revascularization surgery seems to be effective in preventing strokes in Moyamoya 
patients.  The risk of strokes decreases significantly with the direct revascularization. The stroke 
rate in asymptomatic patients is 3.2% per year, once a patient has become symptomatic, the risk 
of recurrent stroke is much higher, with the reported range in the literature being 10.3% per year 
to 16% per year or 80.95% at 5 years (Mallory, Bower, Nwojo, Taussky, Wetjen, Varzoni,Hanel, 
& Meyer, 2013).  Patients that were under medication treatment only have a risk of recurrent 
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stroke of 65% in five years.  After bypass surgery, the risk of recurrent stroke or hemorrhage 
within five years is 5.5% (Guzaman & Steinberg, 2010).  Surgical intervention reduces the risk 
of infarction by 89% (Weinberg, Rahme, Aoun, Batjer, & Bendok, 2011). It is well documented 
that surgical revascularization procedures promote sufficient development of collateral 
vasculature, preventing future TIAs and infarction, for that reason the surgical revascularization 
is the recommended treatment for people with Moyamoya disease (Weinberg, Rahme, Aoun, 
Batjer, & Bendok, 2011).       
There was been very little neuropsychological research on Moyamoya in adults, 
especially on the cognitive functioning of Moyamoya patients.  Previous research indicates that 
impairments in intellectual functioning, information processing speed, executive functioning, and 
visual spatial ability can occur (Kuriyama et al., 2008).  These impairments are associated with 
the cerebral blood flow (CBF), where Moyamoya patients with a higher baseline of CBF seem to 
have better cognitive functioning (Mogensen et al., 2012).  Although the study of improvement 
in cognition after revascularization in Moyamoya patients is in its early stages, there are 
indications that cognitive dysfunction in adults with Moyamoya disease may be potentially 
reversible provided that revascularization surgery is performed before extensive brain infarction 
develops (Calviere et al., 2011).  Thus, the goal of the current study is to investigate the 
improvement of cognition in Moyamoya patients after a revascularization surgical intervention, 
adding to the much-needed research on Moyamoya.  The following outcomes were 
hypothesized: 
1. Diagnostically confirmed Moyamoya patients will show cognitive dysfunction. 
2. Direct Revascularization will improve physiological symptoms 
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3. Direct Revascularization (EC-IC bypass) will reestablish regular blood flow, 
improving perfusion post-operatively, thus increasing cognitive functioning. 
 
Method 
 
Participants  
In this study, 33 patients were diagnosed with Moyamoya accordingly to the criteria 
established by the Research Community on Spontaneous Occlusion of the Circle of Willis 
(Moyamoya Disease) of the Ministry of  Health and Welfare of Japan and treated at the Mayo 
Clinic, in Jacksonville, Florida.  No incentives were given to participants in this study.  The 
exclusion criteria for the current study were patients younger than 18 years old, patients without 
Moyamoya disease or Moyamoya syndrome, and patients not treated at the Mayo Clinic, 
Jacksonville.  Five males and twenty-eight females participated in the study and the majority 
(82%) was Caucasian.  All participants were at least 18 years of age (M = 51.63 years; SD= 
15.19).   
Procedure 
All participants were treated in accordance with the ethical principles and Code of 
Conduct of the American Psychological Association.  Between January 2008 and December 
2012, 33 adult patients with neurodiagnostically confirmed Moyamoya disease underwent 
presurgical neuropsychological assessment and physiological evaluation and three postsurgical 
assessments.   
A pre and posttest design was implemented for this study.  All participants underwent 
pre-surgery physiological and cognitive evaluation that served as the baseline to cognitive 
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improvement after surgery.  After the revascularization surgery, patients returned for three 
assessments to evaluate progress on cognitive and physiological abilities: the first assessment 
was between day 7 and 10 postsurgery; the second assessment between day 30 and 45; and the 
third assessment after 5 to 6 months.    
 
Assessments 
Physiological evaluation. Neurosurgeons at the Mayo Clinic examined the patients and 
their medical history was taken into consideration.  All patients were symptomatic for their 
preoperative evaluation.   Data on whether they currently have or have had a history of TIA, 
strokes, seizures, hemorrhage, and headaches were recorded.  Patients’ mobility was recorded; if 
they were walking by themselves without any assistance, if the patient was using a medical 
walker, or if the patient was in a wheelchair. Patient’s reflexes were also recorded.   
Every patient in this study underwent a battery of brain imaging tests, including MRI, 
Computed tomography angiography (CTA), angiography, and a Magnetic Resonance Angiogram 
(MRA).  Every one of these brain imaging tests can be used to diagnose Moyamoya.   Currently, 
there is no preferable test to diagnose Moyamoya.  The contrast provided by the MRI, 
between grey and white matters make it a good choice when dealing with cerebral vascular 
diseases like Moyamoya.  The CTA is a computed tomography technique used to visualize 
arterial and venous vessels throughout the body. This procedure is able to detect narrowing of 
blood vessels, which is essential when diagnosing Moyamoya.  The angiography is a medical 
imaging technique used to visualize the inside of blood vessels. The MRA is used to generate 
images of in order to evaluate them for stenosis and occlusions. The exams were necessary to 
confirm the disease and to find the location of the blockage.   
11 
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During the postsurgery assessment, doctors looked for new symptoms, stabilization or 
improvements of old ones, new strokes, and the number of seizures since surgery had occurred.  
It was crucial to report patients’ improvements in every aspect.  Although some patient did report 
headache after the surgery, there was not any new strokes, episodes of seizure, nor hemorrhage 
in the postsurgery assessments.  After the last assessment, patients underwent further MRA 
testing to confirm that regular cerebral blood flow had been reestablished.   
 
Cognitive evaluation. A pre- and postsurgery evaluation was given to every Moyamoya 
patient.  Doctors at the Mayo Clinic were interested in patient progress in memory, speech, and 
intellectual processes. The test used in this study is not a standard test used in neuropsychology, 
nonetheless it is a standard test used in all three Mayo Clinic sites when assessing Moyamoya 
patients. The same tests were used in the study “surgical outcomes of stroke in a North American 
White and African American  Moyamoya population” published in 2013 by the Journal of 
Neurosurgery (Mallory, Bower, Nwojo, Taussky, Wetjen, , Varzoni, , Hanel,  & Meyer, 2013). 
 For speech, it was analyzed if the patients were able to communicate with the doctor.  
The content of the conversations, and the fluency were taken into consideration.  For fluency the 
doctors analyzed if the patient’s speech had normal rate and rhythm, if it was slow, rapid, 
slurred, unintelligible, or mute.  The content was reported if the answers were circumstantial, 
coherent, or hard to follow.  Patients were rated from 0 to 2, where 0 means no impairment, 1 
impaired, and 2 highly impaired.  
For memory, patients were asked to name three common objects present on the doctor’s 
office table; such as coffee mug, notepad, pencil, or paper clips.  They were also asked four to 
five questions.  Some questions referred to autobiographic and episodic memory (e.g., What is 
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your name?  What is your date of birth?  What is the name of your oldest child?  In what city 
were you born?)  Questions of declarative memory were also asked, for example, Who is the 
president of the United States?  What day is today?  It was recorded if the patient knew the 
answer, understood the question but did not know the answer, or did not understand the question.  
The same scale for speech was used, with 0 meaning no impairment, 1 impaired, and 2 highly 
impaired.  
For intellectual processes, patients were asked to follow simple commands, such as 
“Please touch your nose with your index finger” or “Can you handle me the coffee mug next to 
the computer, please?”  It was also recorded if the patients were aware of time, space, and 
person, which means if the patient knew who they were, where they were, and when the 
appointment was taking place.  One patient, for example, knew she was at the hospital, but could 
not tell in what city the hospital was located, although she had been born and raised in 
Jacksonville, Florida.  The same scale for speech was used, with 0 meaning no impairment, 1 
impaired, and 2 highly impaired. 
To be consistent, every patient saw the same doctor for the preoperative evaluation and 
the three follow-up assessments.  These tests might seem simple, but many patients could not 
have undergone long standardized tests.  Most patients presented with highly impaired speech, 
and it would have been very difficult to assess their cognitive functions using more complex 
methods. 
 
Results 
The direct revascularization, EC-IC Bypass, was successful for all 33 patients. The 
regular cerebral blood flow was reestablished improving perfusion post-operatively. Figure 1 
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shows preoperative and postoperative angiograms of a 48 years old female with Moyamoya 
disease who underwent the bypass. A, preoperative angiogram. B and C, postoperative 
angiogram after 5 to 6 months. 
 
Figure 1. Pre-operative and post-operative angiograms 
 
 
Physiological Symptoms  
 
Table 1 
 Preoperative Symptoms in 33 patients undergoing revascularization for Moyamoya Disease 
 
Symptoms   n(%) n=33 
Hemorrhage   3(9)   
TIA 12(36) 
Ischemic Stroke 20(61) 
Headaches   8(24) 
Seizures   1(3) 
 
Results showed a significant reduction of physiological symptoms.  No patients reported 
new strokes, episodes of seizure, or hemorrhage in the postsurgery assessments.  They reported 
less frequent episodes of transient ischemic attacks and headaches when compare their 
presurgical state.  The MRIs, angiograms, CTAs, and MRAs showed that the regular blood flow 
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had been reestablished, indicating that the direct revascularization, EC-IC bypass, had been 
successful.  These results are consistent with results from previous research on Moyamoya, 
which indicates physiological improvement after revascularization (Guzman, 2008). 
 
Figure 2. Decrease in physiological symptoms  
            
 
Not only did physiological symptoms decrease, but also cognitive functioning improved 
postsurgery.  Regarding the cognitive evaluation, there was a significant improvement in speech 
and memory.  The next sections address the results for the memory, speech, and intellectual 
processes.  
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Memory 
            Figure 3. Memory improvement shown after surgery. 
 
 
Figure 3 shows improvement in memory; it was calculated based on the decrease of 
memory impairment.  The pre-surgical values demonstrate higher numbers, thus indicating 
greater impairment. The higher the number, the higher the impairment; the following 
assessments indicate lower scores for impairment, revealing improvement in memory. Table 2 
shows the descriptive statistics for all participants from the memory test conducted postsurgery. 
Table 2 
Descriptive Statistics – Overall Memory Improvement 
Assessments Mean SD N 
Pre-Surgery .40 .76 25 
7- 10 days .28 .46 25 
30-45days .12 .33 25 
5 – 6 months  .04 .20 25 
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Overall, there was a marginally significant improvement in memory from before surgery 
to after surgery (Wilks’ Lambda = .79, F(3, 22) = 2.00, p = .14, partial eta squared = .21). 
Following Cohen (1988), effect sizes of .01 are small, .06 are moderate, and .14 are large.  Thus, 
the effect size is very large. 
Pairwise comparisons show significant difference (improvement) between condition pre-
surgery and 30-45 days, pre-surgery and 5-6 months, and 7-10 days and 5-6 months, however 
there was no significant difference found between pre-surgery and 7-10 days and between 30-45 
days and 5-6 months.   
Speech  
Figure 4. Speech improvement shown after surgery.            
 
Figure 4 shows improvement in speech; it was calculated based on the decrease of speech 
impairment.  The pre-surgical values demonstrate higher numbers, thus indicating greater 
impairment. The higher the number, the higher the impairment; the following assessments 
indicate lower scores for impairment, revealing improvement in speech.  
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Table 3 shows the descriptive statistics for all participants from the speech test conducted 
postsurgery. 
 
 
Table 3  
Descriptive Statistics – Overall Speech Improvement 
Assessments Mean SD N 
Pre-Surgery .96 .93 23 
7- 10 days .48 .59 23 
30-45days .26 .45 23 
5 – 6 months  .09 .29 23 
 
Overall, there was a significant improvement in speech pre and postsurgery (Wilks’ 
Lambda = .51, F(3, 20) = 6.32, p = .003, partial eta squared = .49).  Partial eta squared effect 
sizes of .01 are small, .06 are moderate, and .14 are large; thus, the effect size of our findings is 
very large.  
Pairwise comparisons show significant differences between all four conditions, except 
between assessment 30-45 days and 5-6 months. 
 
Intellectual Processes   
Figure 5 shows improvement in intellectual process; it was calculated based on the 
decrease of intellectual process impairment.  The pre-surgical values demonstrate higher 
numbers, thus indicating greater impairment. The higher the number, the higher the impairment; 
the following assessments indicate lower scores for impairment, revealing improvement in 
intellectual process. 
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Figure 5. Intellectual process improvement, pre and postsurgery. 
      
  
Table 4 shows the descriptive statistics for all participants from the intellectual processes 
test conducted postsurgery. 
 
Table 4 
Descriptive Statistics – Overall Intellectual Processes Improvement 
Assessments Mean SD N 
Pre-Surgery .54 .88 13 
7 -10 days .31 .63 13 
30 - 45 days .23 .44 13 
5 - 6 months  .08 .28 13 
 
Overall, there was no significant improvement in questions/general knowledge from 
before surgery to after surgery (Wilks’ Lambda = .69, F(3, 10) = 1.48, p = .28, partial eta 
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squared = .31).  Since partial eta squared effect sizes of .01 are small, .06 are moderate, and .14 
are large, the effect size of our findings is very large, showing the strength of the phenomenon.  
The non-significant result is probably due to the small sample size of 13.  Pairwise comparisons 
show significant differences only between condition pre-surgery and 5-6 months. 
 
Discussion 
It was hypothesized that that hypoperfusion, decrease of blood flow, was the principal 
cause of cognitive decline in adults Moyamoya patients.  In turn, improved perfusion post-
operatively was hypothesized to correlate with improved cognitive functioning, and this study 
failed to reject this hypothesis.  The findings are consistent with previous research on 
Moyamoya, physiological improvement was expected (Guzman, 2009), and in this study, we 
were able to confirm reduction of physiological symptoms postsurgery.  This study is in 
agreement with researches that suggest that cognitive impairment can be expected in Moyamoya 
patients and that direct bypass is a reliable treatment for this condition.  After the surgical 
procedure and direct bypass, and after regular blood flow had been reestablished, cognitive 
functions significantly improved in Moyamoya patients.  
Patients presented a consistent significant improvement in speech during the first two 
assessments.  Between 7 to 10 days and between 30 to 45 days after surgery, a significant 
improvement in speech was observed overall.  Patients presented more fluency in their speech 
with more coherent conversation, and the doctors reported improvement in how and what was 
being said, not only the patients were pronouncing the words clearer, but the content of the 
conversation was more meaningful. 
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 Memory showed improvement as well, but only one month after surgery.  It appears to be 
a more progressive change, instead of a sudden improvement as was speech.  Patients were able 
to recall not only names and birth dates of loved ones, but were also able to answer general 
knowledge questions, such as “Who is the president of the US?”  They were also able to name 
common office objects like notepads, mugs, and paper clips.  
Unfortunately, intellectual processes did not differ significantly between assessments; 
however, results showed a large effect size.  A possible explanation could be the small sample 
size.  Another possible explanation could be that for the first three assessments, over 80% of 
patients received a score of “0”.  Thus, there was a floor effect.  This means that when the patient 
received a “0”, not impaired, many times the doctor believed there was no need to keep asking 
the same question in subsequent assessments, causing the difference between number of 
participants and number of collected data. Example: there were 33 patients in this study, however 
only 13 patients complete the 3 postsurgical assessments for intellectual processes.   
The results of this study support continuing clinical attention and intervention efforts 
directed at early identification and treatment, early surgical revascularization interventions to 
prevent further decline and improve cognitive outcome. Healthcare providers can utilize the 
findings of this research to prepare and help manage concerns of these patients pre- and 
postsurgery better.  
 
Limitations to the Study 
There were multiple limitations to this study.  First and most saliently, our sample size, 
even though the number of participants (33) in the current study is considered an exceptional 
number for such a rare disease like Moyamoya, it is still a small sample, substantially limited 
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analytical statistical power, as well as precluding use of multivariate techniques, because of our 
small sample size our finding should be considered preliminary and interpreted with caution. 
They need to be confirmed in a large number of patients. However, the findings were statistically 
significant and consistent with previous knowledge of Moyamoya disease.   Second, one 
neurosurgeon rated all patients.  It would be desirable to have multiple ratings to calculate 
interrater reliability.  Third, the scale used in this study was from 0 to 2, if a more sensitive 
scaled were used, perhaps expanding the scale from 0 to 5, it could have shown more subtle 
improvements in cognition. 
The sample demographics could arguably provide for biases.  Study participants lacked 
diversity, as most patients were White women, over the age of 50 years, and of mid to high 
socioeconomic status, possibly contributing to limitations of the study’s generalizability.  Future 
studies could also include children with Moyamoya disease and more people from different 
ethnical groups. 
Another limitation was that many patients were not from Florida where the surgery and 
assessment took place, and to complete all three postsurgery assessments was a logistical barrier.  
This was because when patients started to feel better, they wanted to go home and to their local 
neurologist for check up visits instead of coming to Florida, thus not all of the patients come to 
the third assessment. 
 
Conclusions 
Further research is warranted to bring awareness to this serious but treatable disease.  
Few studies both in the United States and around the world have been conducted using a large 
sample of Moyamoya patients and specifically assessing them on neuropsychological and 
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psychological functioning.  This study adds to the research as it has identified some unique 
issues of this disease and the benefits of the direct revascularization procedure to improve 
cognition.  More research can only strengthen these findings and educate healthcare 
professionals, helping them assure the patients of a better quality of life and reinforcing the 
benefits of revascularization surgery for treatment of Moyamoya disease. 
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